Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index von Kim, Dae Hyun, Schneeweiss, Sebastian, Glynn, Robert J, Lipsitz, Lewis A, Rockwood, Kenneth, Avorn, Jerry

Volltext

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial von Ridker, Paul M, Prof, Pradhan, Aruna, MD, MacFadyen, Jean G, BA, Libby, Peter, Prof, Glynn, Robert J, Prof

Volltext

Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study von Kim, Dae Hyun, Glynn, Robert J, Avorn, Jerry, Lipsitz, Lewis A, Rockwood, Kenneth, Pawar, Ajinkya, Schneeweiss, Sebastian

Volltext

A combined comorbidity score predicted mortality in elderly patients better than existing scores von Gagne, Joshua J, Glynn, Robert J, Avorn, Jerry, Levin, Raisa, Schneeweiss, Sebastian

Volltext

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events von Ridker, Paul M, Everett, Brendan M, Pradhan, Aruna, MacFadyen, Jean G, Solomon, Daniel H, Zaharris, Elaine, Mam, Virak, Hasan, Ahmed, Rosenberg, Yves, Iturriaga, Erin, Gupta, Milan, Tsigoulis, Michelle, Verma, Subodh, Clearfield, Michael, Libby, Peter, Goldhaber, Samuel Z, Seagle, Roger, Ofori, Cyril, Saklayen, Mohammad, Butman, Samuel, Singh, Narendra, Le May, Michel, Bertrand, Olivier, Johnston, James, Paynter, Nina P, Glynn, Robert J

Volltext

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy von Mora, Samia, Glynn, Robert J., Ridker, Paul M

Volltext

Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes von Kutz, Alexander, Kim, Dae Hyun, Wexler, Deborah J, Liu, Jun, Schneeweiss, Sebastian, Glynn, Robert J, Patorno, Elisabetta

Volltext

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients von Ridker, Paul M, Revkin, James, Amarenco, Pierre, Brunell, Robert, Curto, Madelyn, Civeira, Fernando, Flather, Marcus, Glynn, Robert J, Gregoire, Jean, Jukema, J. Wouter, Karpov, Yuri, Kastelein, John J.P, Koenig, Wolfgang, Lorenzatti, Alberto, Manga, Pravin, Masiukiewicz, Urszula, Miller, Michael, Mosterd, Arend, Murin, Jan, Nicolau, Jose C, Nissen, Steven, Ponikowski, Piotr, Santos, Raul D, Schwartz, Pamela F, Soran, Handrean, White, Harvey, Wright, R. Scott, Vrablik, Michal, Yunis, Carla, Shear, Charles L, Tardif, Jean-Claude

Volltext

Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis von Everett, Brendan M., MD, MPH, Pradhan, Aruna D., MD, MPH, Solomon, Daniel H., MD, MPH, Paynter, Nina, PhD, MacFadyen, Jean, BA, Zaharris, Elaine, BA, Gupta, Milan, MD, Clearfield, Michael, DO, Libby, Peter, MD, Hasan, Ahmed A.K., MD, PhD, Glynn, Robert J., ScD, Ridker, Paul M., MD, MPH

Volltext

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data von Schneeweiss, Sebastian, Rassen, Jeremy A., Glynn, Robert J., Avorn, Jerry, Mogun, Helen, Brookhart, M. Alan

Volltext

Emulation Differences vs. Biases When Calibrating Real‐World Evidence Findings Against Randomized Controlled Trials von Franklin, Jessica M., Glynn, Robert J., Suissa, Samy, Schneeweiss, Sebastian

Volltext

Ventricular arrhythmias and sudden death in patients taking ibrutinib von Lampson, Benjamin L., Yu, Lijian, Glynn, Robert J., Barrientos, Jacqueline C., Jacobsen, Eric D., Banerji, Versha, Jones, Jeffrey A., Walewska, Renata, Savage, Kerry J., Michaud, Gregory F., Moslehi, Javid J., Brown, Jennifer R.

Volltext

Propensity Score Weighting and Trimming Strategies for Reducing Variance and Bias of Treatment Effect Estimates: A Simulation Study von Stürmer, Til, Webster-Clark, Michael, Lund, Jennifer L, Wyss, Richard, Ellis, Alan R, Lunt, Mark, Rothman, Kenneth J, Glynn, Robert J

Volltext

Using propensity scores to estimate effects of treatment initiation decisions: State of the science von Webster‐Clark, Michael, Stürmer, Til, Wang, Tiansheng, Man, Kenneth, Marinac‐Dabic, Danica, Rothman, Kenneth J., Ellis, Alan R., Gokhale, Mugdha, Lunt, Mark, Girman, Cynthia, Glynn, Robert J.

Volltext

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial von Ridker, Paul M, Prof, Dr, Danielson, Eleanor, MIA, Fonseca, Francisco AH, MD, Genest, Jacques, Prof, Gotto, Antonio M, Prof, Kastelein, John JP, Prof, Koenig, Wolfgang, Prof, Libby, Peter, Prof, Lorenzatti, Alberto J, Prof, MacFadyen, Jean G, BA, Nordestgaard, Børge G, Prof, Shepherd, James, Prof, Willerson, James T, Prof, Glynn, Robert J, ScD

Volltext

Comparison of Risk Factors for the Competing Risks of Coronary Heart Disease, Stroke, and Venous Thromboembolism von Glynn, Robert J., Rosner, Bernard

Volltext

Benzodiazepines and risk of all cause mortality in adults: cohort study von Patorno, Elisabetta, Glynn, Robert J, Levin, Raisa, Lee, Moa P, Huybrechts, Krista F

Volltext

Effects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates von Myers, Jessica A., Rassen, Jeremy A., Gagne, Joshua J., Huybrechts, Krista F., Schneeweiss, Sebastian, Rothman, Kenneth J., Joffe, Marshall M., Glynn, Robert J.

Volltext

One-to-many propensity score matching in cohort studies von Rassen, Jeremy A., Shelat, Abhi A., Myers, Jessica, Glynn, Robert J., Rothman, Kenneth J., Schneeweiss, Sebastian

Volltext

Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study von Patorno, Elisabetta, Pawar, Ajinkya, Wexler, Deborah J., Glynn, Robert J., Bessette, Lily G., Paik, Julie M., Najafzadeh, Mehdi, Brodovicz, Kimberly G., Déruaz‐Luyet, Anouk, Schneeweiss, Sebastian

Volltext